retatrutide dosing clinical trial retatrutide dose frequency microdosing: guide to split protocols and schedules The Dosage Chart: A – Retatrutide Dosage: What Clinical Trial

confusing the two could cause serious dosing errors

your provider will follow the appropriate clinical protocols to start you at the lowest dose and move up as needed

They help lower HbA1c levels, which reflect average blood glucose levels over time

Expected outcomes based on trial data: Average weight loss of 24.2% at 48 weeks (phase 2) Average weight loss of 28.7% at 68 weeks (phase 3, TRIUMPH-4) 100% of participants achieved 5% or greater weight loss 93% achieved 10% or greater 83% achieved 15% or greater Moderate weight loss protocol (8mg target) For researchers who want significant weight loss but have a lower tolerance for side effects, stopping the escalation at 8mg is a validated approach

Check with your physician to confirm your stop date as a longer period may be recommended

But did you know that GLP-1 does much more than just help shed pounds